SEC Form 4 · accession 0001628280-26-040578
NEOGENOMICS INC · NEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lynn A. Tetrault
Director
Period of report
Jun 1, 2026
Accepted (ET)
Jun 3, 2026 · 7:47 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001077183
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 1, 2026 | M | 23,077 | $0.00 | A | 96,729 | D | |
| Common Stock | holding | — | — | — | 7,000 | I | Lynn Tetrault Rollover IRA |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF2 | $0.00 | Jun 1, 2026 | M | 23,077 | D | Jun 1, 2026 | — | Common Stock | 23,077 | 0 | D |
| Stock Option (Right to Buy) | $10.52 | Jun 1, 2026 | A | 11,069 | A | Jun 1, 2027 | Jun 1, 2036 | Common Stock | 11,069 | 11,069 | D |
| Restricted Stock UnitF2 | $0.00 | Jun 1, 2026 | A | 15,970 | A | Jun 1, 2027 | — | Common Stock | 15,970 | 15,970 | D |
| Stock Option (Right to Buy) | $22.52 | holding | — | — | — | Jun 6, 2020 | Jun 6, 2026 | Common Stock | 2,136 | 2,136 | D |
| Stock Option (Right to Buy) | $28.54 | holding | — | — | — | May 28, 2021 | May 28, 2027 | Common Stock | 3,448 | 3,448 | D |
| Stock Option (Right to Buy) | $40.90 | holding | — | — | — | Jun 2, 2022 | Jun 2, 2028 | Common Stock | 3,714 | 3,714 | D |
| Stock Option (Right to Buy) | $41.76 | holding | — | — | — | Oct 11, 2022 | Oct 11, 2028 | Common Stock | 972 | 972 | D |
| Stock Option (Right to Buy) | $8.10 | holding | — | — | — | Jun 10, 2023 | Jun 10, 2029 | Common Stock | 13,882 | 13,882 | D |
| Stock Option (Right to Buy) | $14.82 | holding | — | — | — | Aug 10, 2024 | Aug 10, 2033 | Common Stock | 8,353 | 8,353 | D |
| Stock Option (Right to Buy) | $13.71 | holding | — | — | — | Jun 1, 2025 | Jun 1, 2034 | Common Stock | 8,672 | 8,672 | D |
| Stock Option (Right to Buy) | $7.28 | holding | — | — | — | Jun 1, 2026 | Jun 1, 2035 | Common Stock | 16,107 | 16,107 | D |
Explanation of responses
- F1Reflects release of restricted stock units that were previously reported on a Form 4.
- F2Once vested, the shares of common stock are not subject to expiration.